Zomet 500mg Tablet SR contains Metformin hydrochloride, a biguanide class oral antihyperglycemic agent used primarily in the management of type 2 diabetes mellitus. Metformin works by decreasing hepatic glucose production, decreasing intestinal absorption of glucose, and improving insulin sensitivity by increasing peripheral glucose uptake and utilization. This sustained-release formulation ensures a gradual release of the active ingredient, promoting better glycemic control with reduced gastrointestinal side effects compared to immediate-release forms. Zomet 500mg Tablet SR is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes, particularly in overweight patients or those who have failed to achieve adequate control with lifestyle modifications alone. It may be used as monotherapy or in combination with other antidiabetic agents, including insulin. The medication is contraindicated in patients with renal impairment, metabolic acidosis, or known hypersensitivity to Metformin. Regular monitoring of renal function and blood glucose levels is essential during therapy. Common adverse effects include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort, which often subside with continued use. Zomet 500mg Tablet SR should be taken as prescribed by a healthcare professional to optimize therapeutic outcomes and minimize risks.